The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...

More than ever, pharma firms are under increasing pressure to harness the power of AI, advanced analytics, and machine ...

Amazon Web Services (AWS) has committed $100 million in AI and cloud technology capacity to support the building of health ...

The comprehensive failure of Lp (a)HORIZON has cast a pall over the prospects for other Lp (a)-targeting drugs, including ...

Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly valued at around £2.2 billion (€2.6 billion), although financial terms are not ...

Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies Zepbound and Foundayo sold ...

Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...

Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...

Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...

Moderna's mRNA-1469 and ChAdOx1, developed by the University of Oxford in partnership with the Serum Institute of India, ...

Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in the third ...